BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7856587)

  • 1. Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
    Barthes DM; Rochard EB; Pouliquen IJ; Rabouan SM; Courtois PY
    Am J Hosp Pharm; 1994 Nov; 51(21):2706-9. PubMed ID: 7856587
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
    Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
    Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical and chemical stability of paclitaxel infusions in different container types.
    Donyai P; Sewell GJ
    J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
    Belliveau PP; Nightingale CH; Quintiliani R
    Am J Hosp Pharm; 1994 Apr; 51(7):901-4. PubMed ID: 8017440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinevac stability after reconstitution with sodium chloride injection USP, 0.9%.
    Littleton LT; Fileta BB; Massey R; Wood TI
    J Nucl Med Technol; 2009 Mar; 37(1):57-9. PubMed ID: 19223430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
    Belliveau PP; Shea BF; Scavone JM
    Am J Hosp Pharm; 1993 May; 50(5):950-2. PubMed ID: 8506875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
    Millar AM; O'Brien LM
    Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions.
    de Lemos ML; Hamata L; Vu T
    J Oncol Pharm Pract; 2005 Dec; 11(4):155-7. PubMed ID: 16595068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
    Xu Q; Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
    Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
    Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of etoposide solution for oral use.
    McLeod HL; Relling MV
    Am J Hosp Pharm; 1992 Nov; 49(11):2784-5. PubMed ID: 1471649
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility study of 5-fluorouracil with PVC bags after repackaging into two types of infusion admixtures.
    Benaji B; Faouzi MA; Dine T; Goudaliez F; Luyckx M; Brunet C; Kablan J; Gressier B; Cazin M; Cazin JC
    Therapie; 1999; 54(5):659-63. PubMed ID: 10667105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug precipitation and peristaltic pumps.
    Woloschuk DM
    Am J Hosp Pharm; 1994 Jun; 51(11):1473. PubMed ID: 7942882
    [No Abstract]   [Full Text] [Related]  

  • 17. Etoposide in continuous infusion: practical recommendations for pediatric protocols.
    Bauters T; Vandenbroucke J; Moerloose BD; Porre JD; Benoit Y; Robays H
    J Oncol Pharm Pract; 2011 Dec; 17(4):453-5. PubMed ID: 22130773
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
    Li M; Coursol C; Leclair G
    Am J Health Syst Pharm; 2013 Nov; 70(22):1970-2. PubMed ID: 24173005
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
    Sadou Yayé H; Hassani L; Secrétan PH; Babiard M; Aouati H; Bellanger A; Tilleul P; Yagoubi N; Do B; Rietveld IB
    J Pharm Biomed Anal; 2020 Jan; 178():112896. PubMed ID: 31600662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days.
    Hagan RL; Jacobs LF; Pimsler M; Merritt GJ
    Am J Hosp Pharm; 1993 Nov; 50(11):2379-81. PubMed ID: 8266971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.